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Palmitoylation, a key regulatory mechanism control-
ling protein targeting, is catalyzed by DHHC-family
palmitoyl acyltransferases (PATs). Impaired PAT
activity is linked to neurodevelopmental and neuro-
psychiatric disorders, suggesting critical roles for
palmitoylation in neuronal function. However, few
substrates for specific PATs are known, and func-
tional consequences of palmitoylation events are
frequently uncharacterized. Here, we identify the
closely related PATs DHHC5 and DHHC8 as specific
regulators of the PDZ domain protein GRIP1b.
Binding, palmitoylation, and dendritic targeting of
GRIP1b require a PDZ ligand unique to DHHC5/8.
Palmitoylated GRIP1b is targeted to trafficking endo-
somes and may link endosomes to kinesin motors.
Consistent with this trafficking role, GRIP1b’s palmi-
toylation turnover rate approaches the highest of all
reported proteins, and palmitoylation increases
GRIP1b’s ability to accelerate AMPA-R recycling.
To our knowledge, these findings identify the first
neuronal DHHC5/8 substrate, define novel mecha-
nisms controlling palmitoylation specificity, and
suggest further links between dysregulated palmi-
toylation and neuropathological conditions.
INTRODUCTION
Precise targeting of proteins to specific subcellular locations is
critical in all cells, but its importance is especially apparent in
highly specialized, polarized cells such as neurons. Neuronal
protein targeting must be precisely regulated to control neuro-
transmission at specific synapses, which in turn underlies higher
brain functions such as synaptic plasticity, learning, andmemory482 Neuron 73, 482–496, February 9, 2012 ª2012 Elsevier Inc.(Shepherd and Huganir, 2007; Newpher and Ehlers, 2008; Lau
and Zukin, 2007).
A major mechanism that controls protein targeting to specific
subcellular locations is direct lipid modification, which facilitates
protein interactions with intracellular or plasma membranes
(Johnson et al., 1994; Zhang and Casey, 1996; el-Husseini and
Bredt, 2002; Fukata and Fukata, 2010). Of the three most
common lipid modifications, myristoylation, prenylation and
palmitoylation, only palmitoylation is reversible. This allows addi-
tional dynamic regulation and may be one reason why palmitoy-
lation is more frequently observed in neurons than other lipid
modifications (Fukata and Fukata, 2010). Indeed, palmitoylation
is rapidly emerging as a critical modulator of neuronal function,
whose disruption is linked to neurodevelopmental and neuro-
psychiatric conditions (Fukata and Fukata, 2010; Mukai et al.,
2004, 2008; Mansouri et al., 2005; Raymond et al., 2007).
In mammalian cells, palmitoylation is catalyzed by a family of
palmitoyl acyltransferases (PATs), each containing a conserved
Asp-His-His-Cys (DHHC) motif (Fukata et al., 2004). Many
PATs are expressed in neurons (Heiman et al., 2008; Doyle
et al., 2008), but two PATs, DHHC5 and DHHC8, are detected
far more frequently than others at both the mRNA and protein
levels in neuronal studies (Trinidad et al., 2006, 2008; Munton
et al., 2007; Heiman et al., 2008; Doyle et al., 2008). This
suggests that DHHC5/8 might be particularly important in
neuronal regulation. Consistent with this hypothesis, DHHC5 is
implicated in higher brain function, since mice with reduced
DHHC5 levels (a hypomorphic ‘‘gene trap’’ line) show impaired
performance in a learning task (Li et al., 2010). Moreover,
neurons from DHHC8 knockout mice have a reduced density
of dendritic spines and glutamatergic synapses (Mukai et al.,
2008). In addition to their physiological roles, both DHHC5 and
DHHC8 are linked to neuropsychiatric conditions. The ZDHHC5
gene, which codes for DHHC5, lies in a region of chromosome 11
associated with bipolar disorder (Fallin et al., 2004), while the
ZDHHC8 gene lies in a region of chromosome 22 repeatedly
implicated in schizophrenia (Mukai et al., 2004; Chen et al.,
2004). Palmitoylation of neuronal proteins by DHHC5/8 is,
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be impaired in disease states. However, little is known regarding
the direct neuronal substrates of DHHC5/8.
Here, we identify a specific splice form of the multi-PDZ
domain containing protein GRIP1b as a novel neuronal substrate
for DHHC5/8. Palmitoylated GRIP1b, which is targeted to
trafficking endosomes, serves as a specific link between
endosomes and microtubule motors. This localization places
palmitoylated GRIP1b in a perfect position to mediate activity-
dependent AMPA-R trafficking, a role we recently revealed for
GRIP1. Indeed, palmitoylation enhances GRIP1b’s ability to
accelerate AMPA-R recycling. Strikingly, binding, palmitoylation,
and dendritic targeting of GRIP1b by DHHC5 all require a novel
PDZ ligand-dependent recognition mechanism. These findings
not only identify a neuronal DHHC5/8 substrate, but also define
additional mechanisms controlling palmitoylation specificity.
RESULTS
DHHC5 and DHHC8 Bind and Palmitoylate GRIP1b
DHHC5 and DHHC8 are closely related but differ markedly in
structure from all other PATs because they possess greatly
extended C-terminal tails (Fukata et al., 2004; Ohno et al.,
2006). We hypothesized that these tails might provide clues to
the possible specific roles and targets of DHHC5/8. In particular,
we noticed that both tails end with a motif that is predicted to
bind to PDZ domain-containing proteins (Kim and Sheng,
2004; Feng and Zhang, 2009). PDZ domain proteins are heavily
implicated in many aspects of neuronal regulation but are
especially known to control the targeting and trafficking of gluta-
mate receptors (Kornau et al., 1995; Dong et al., 1997; Srivastava
et al., 1998; Steinberg et al., 2006; Daw et al., 2000; Osten
et al., 2000; Wyszynski et al., 2002; Terashima et al., 2008;
Hanley, 2008). We, therefore, hypothesized that DHHC5/8
might use their C-terminal motif to bind specific PDZ domain
proteins and potentially to recognize them as substrates for
palmitoylation.
The DHHC5 andDHHC8C termini are identical and conform to
a type II PDZ ligand (EISV; Figure 1A; Songyang et al., 1997). As
a first step to address the possibility that DHHC5/8 use this
C-terminal motif to bind specific substrates, we performed
a yeast two-hybrid screen of a rat hippocampal cDNA library
using a C-terminal bait that included the shared DHHC5/8 PDZ
ligand. Of 83 106 clones screened, four ‘‘hits’’ encoded an iden-
tical central region (PDZ domains 4–6: ‘‘GRIP1-456’’) of the
multi-PDZ domain adaptor protein GRIP1 (Dong et al., 1997).
Consistent with the fact that their PDZ ligands are identical,
GST fusions of both DHHC5 and DHHC8 C termini bound
robustly to GRIP1-456 in cotransfected HEK293T cells. No
binding of GRIP1-456 was observed with GST alone, or with
DHHC5 or DHHC8 C termini lacking the PDZ ligand (Figures
1B and 1C). PDZ ligand-dependent binding of both DHHC5
and DHHC8 C-terminal tails was also observed when the exper-
iment was performed in the reverse direction (to detect DHHC5/8
tails in myc-GRIP1-456 immunoprecipitates; see Figures S1A
and S1B available online). Moreover, the shared DHHC5/8
C-terminal 15AA sequence was sufficient to robustly bind
GRIP1-456 (Figure S1C).Alternative splicing produces two GRIP1 isoforms, GRIP1a
and GRIP1b, which differ in a unique N-terminal sequence (Fig-
ure 1D; Yamazaki et al., 2001). It was previously reported that
GRIP1b is specifically palmitoylated, although the PAT(s)
responsible was not identified (Yamazaki et al., 2001). To test
whether DHHC5 and/or DHHC8 specifically palmitoylates
GRIP1b, we optimized a nonradioactive acyl-biotinyl exchange
(ABE) assay (Hayashi et al., 2009; Wan et al., 2007; Drisdel
et al., 2006). ABE is a chemical exchange of biotin for thio-
ester-linked acyl modifications (i.e., palmitoylation), with the re-
sulting biotinylated protein being affinity purified by neutravidin
agarose. ABE avoids the long exposure times required for [3H]
palmitate incorporation experiments and was used routinely for
this study, although major findings were also shown by [3H]
palmitate incorporation, with essentially identical results (Fig-
ure S1D and Figures 2E).
GRIP1b expressed in HEK293T cells was significantly palmi-
toylated, as detected by ABE, but GRIP1b palmitoylation was
robustly increased by coexpression of either DHHC5 or
DHHC8 (Figures 1E and 1F). In contrast the GRIP1a splice
variant was not palmitoylated, either when expressed alone, or
with DHHC5 or DHHC8 (Figures 1E and 1F). Because GRIP1a
differs from GRIP1b only at its N terminus (Figure 1F), this sug-
gested that DHHC5 and DHHC8 specifically palmitoylate the
unique N-terminal cysteine, Cys11, of GRIP1b. Indeed, point
mutation of GRIP1b Cys11 to a nonpalmitoylatable serine abol-
ished palmitoylation by DHHC5 and DHHC8 (data not shown).
We next examined the ability of specific DHHC5/8 mutants to
palmitoylate GRIP1b. As expected, GRIP1b was not palmitoy-
lated by catalytically inactive PAT mutants (catalytic Cys
mutated to Ser; DHHS5, DHHS8; Figures 1G and 1H). Strikingly,
GRIP1b was also not palmitoylated by DHHC5 and DHHC8
mutants lacking the C-terminal PDZ ligand (Figures 1G and
1H). Quantification of palmitoylated:total GRIP1 levels from
multiple experiments confirmed these results (Figures S1E and
S1F). These findings suggest that DHHC5/8 can bind and palmi-
toylate GRIP1b in heterologous cells, and require both catalytic
activity and PDZ domain binding to recognize GRIP1 as
a substrate.
DHHC5 Is a Major Neuronal PAT for GRIP1b
Little is known regarding the endogenous subcellular distribution
of DHHC5 and DHHC8 and their specific roles in neurons. To
gain insight into whether DHHC5 and/or DHHC8 palmitoylates
GRIP1 in neurons, we first used specific antibodies (Figure S2A)
to immunolocalize these two PATs. Both DHHC5 and DHHC8
were clearly detected in dendrites (Figure 2A). DHHC8 was
largely synaptically localized, as shown by colocalization with
the synaptic active zone protein Bassoon (Figure 2A). In contrast,
DHHC5 colocalized only rarely with Bassoon but was strongly
detected within dendritic shafts (Figure 2A). To confirm DHHC5
distribution, we also expressed epitope-tagged DHHC5 in
hippocampal neurons. Both Myc- and HA-tagged DHHC5 im-
munostaining mirrored the pattern seen for endogenous
DHHC5, being detected occasionally in dendritic spines, but
frequently in dendritic shafts (Figures 2B and S2B). Consistent
with this distribution, myc-DHHC5 puncta colocalized only occa-
sionally with the synaptic marker PSD-95 (Figure 2B).Neuron 73, 482–496, February 9, 2012 ª2012 Elsevier Inc. 483
Figure 1. DHHC5 and DHHC8 Specifically Bind and Palmitoylate GRIP1
(A) Schematic of the structure of DHHC5 and DHHC8, showing predicted transmembrane domains (blue), catalytic DHHC-Cysteine Rich Domain (red), and
identical C-terminal 15 AA sequence (yellow) terminating in identical PDZ ligand (EISV, orange). The region of the DHHC8 C terminus used as bait for yeast two-
hybrid screening is indicated.
(B) HEK293T cells were transfected with myc-tagged GRIP1-PDZ domains 4–6, together with either GST alone (GST), a GST fusion of the C terminus of DHHC5
(GST-5wt), or a GST fusion of the C terminus of DHHC5 lacking the C-terminal PDZ-binding motif (GST-5DC). Inputs (left panels) and GST pull-downs (right
panels) were immunoblotted with anti-myc and anti-GST antibodies.
(C) is the same as (B), except that indicated constructs of DHHC8 were cotransfected.
(D) Comparison of N-terminal sequences of GRIP1a and GRIP1b. The unique cysteine11 of GRIP1b is reported to be palmitoylated in heterologous cells, but the
PAT was not identified.
(E) HEK293T cells were transfected with HA-tagged DHHC5 and either full-length untagged GRIP1a or GRIP1b. ABE was performed to isolate palmitoylated
proteins, and GRIP1 levels in ABE samples were detected by immunoblotting (top panel). Cell lysates were blotted to detect total levels of GRIP1 (middle panel)
and HA-DHHC5 (lower panel). Note that palmitoylated GRIP1 signal is only detected following treatment with hydroxylamine (NH2OH), an essential step of the
ABE reaction.
(F) is the same as (E), except that cells were transfected with mycHis-DHHC8 and either GRIP1a or GRIP1b, and lysates were blotted to detect total levels of
GRIP1 (middle panel) and mycHis-DHHC8 (lower panel).
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GRIP1 Palmitoylation and Targeting by DHHC5/8This extensive dendritic distribution of DHHC5 and DHHC8
contrasted markedly to the ER/Golgi localization reported for
many other PATs (Ohno et al., 2006). To further explore this
difference, we compared DHHC5 distribution with two other
PDZ ligand-containing PATs, DHHC3 and DHHC7. Both
DHHC3 and DHHC7 localized exclusively with a Golgi marker
(Figure S2B) and were absent from dendrites, and quantitative
comparison of DHHC3 and DHHC5 dendritic distribution
confirmed this highly significant difference (Figure S2C).
DHHC5 signals also extended far beyond the somatic signal
seen with the ER marker KDEL-CFP (Figure S2D). Together,
these data suggest that DHHC5 and DHHC8 are present in
dendritic locations in neurons that differ from other PATs, where
they may play unique roles.
Biochemical analysis of DHHC5 and DHHC8 distribution sup-
ported these immunostaining data: DHHC8 was enriched in
postsynaptic density (PSD) fractions, consistent with its synaptic
localization, while DHHC5, though detectable in PSD fractions,
was markedly less enriched, consistent with its more prominent
dendritic distribution (Figure 2C). Fidelity of the PSD preparation
was confirmed by immunoblotting with pre- and postsynaptic
markers (Figure S2E).
The dendritic localization of DHHC5 resembles the previously
reported distribution of GRIP1, which is present throughout
dendritic shafts, but only rarely in dendritic spines (Wyszynski
et al., 1999; Mao et al., 2010; Figure 2D). However, previous
reports of GRIP1 localization did not distinguish between
GRIP1a and GRIP1b. We, therefore, developed a GRIP1b-
specific antibody (characterized in Figure S2F). TheGRIP1b anti-
body recognized numerous dendritic puncta (Figure 2D), which
resembled the previously reported distribution of GRIP1 (Mao
et al., 2010) and overlapped almost entirely with signal detected
by a pan-GRIP1 monoclonal antibody (Figure 2D). By contrast,
GRIP1b colocalized with neither the synaptic marker PSD-95
(Figure S2G) nor the Golgi marker GM130 (Figure S2H).
Together, these data suggest that GRIP1b is largely present in
dendritic puncta, similar to DHHC5. Biochemical data also sup-
ported this conclusion, as subcellular distribution of both GRIP1
and GRIP1b was broadly similar to DHHC5 (Figure S2E).
Although GRIP1b is palmitoylated in heterologous cells,
endogenous GRIP1 palmitoylation is not well characterized in
neurons. Using [3H]palmitate labeling, we first confirmed that
GRIP1 is indeed palmitoylated in primary neurons (Figure 2E).
Immunoblotting of ABE samples with a ‘‘pan-GRIP1’’ antibody
also showed a robust signal, confirming GRIP1 palmitoylation
in both cultured neurons and in intact brain (Figure 2E). To specif-
ically detect GRIP1b palmitoylation, we probed the same ABE
samples with our GRIP1b antibody. Strikingly, this suggested
that a higher percentage of GRIP1b is palmitoylated in neurons
than the well-known palmitoyl-protein PSD-95 (Figure 3A).
Their similar subcellular localization suggests that DHHC5 is
appropriately positioned to palmitoylate GRIP1b in neurons.(G) Palmitoylation of GRIP1b by DHHC5 requires catalytic activity and PDZ binding
HA-tagged DHHC5 wild-type (HA-DHHC5wt), catalytically inactive mutant (HA-D
and immunoblotted to detect palmitoylated GRIP1 (upper panel), GRIP1 express
(H) is the same as (G), except that cells were transfected with GRIP1b plus eithe
See also Figure S1 for additional control experiments and quantified data.Indeed, although GRIP1b protein was detected as early as
5 days in vitro [DIV] (Figure 2F), GRIP1b palmitoylation was de-
tected only at later times (12–19 DIV), coincident with the
appearance of DHHC5 (Figure 2F). Moreover, neurons infected
with lentivirus encoding a small hairpin RNA (shRNA) that specif-
ically targets DHHC5 (Figure S2I) showed markedly reduced
levels of palmitoylated, but not total, GRIP1 (Figures 2G and
2H). Importantly, as a control for potential off-target effects of
shRNA, both DHHC5 levels and GRIP1 palmitoylation were
rescued by coexpression of shRNA-resistant DHHC5 (Figures
2G and 2H). DHHC5 knockdown and rescue did not affect either
palmitoylated or total levels of the known palmitoyl proteins Fyn
(Figure 2G) or SNAP25 (data not shown).
DHHC5 knockdown did not completely eliminate GRIP1b pal-
mitoylation, suggesting that other PATs, in particular DHHC8,
might compensate for loss of DHHC5. Indeed, while infection
of a DHHC8-specific (Figures S2J and S2K) shRNA only slightly
reduced GRIP1 palmitoylation, coinfection with shRNAs target-
ing DHHC5 and DHHC8 together reduced GRIP1 palmitoylation
to almost undetectable levels (Figures 2G and 2H). Levels of total
and palmitoylated SNAP25 and Fyn were unaffected, even in
DHHC5 plus DHHC8 knockdown neurons. These results
strongly suggest that both DHHC5 and DHHC8 can palmitoylate
GRIP1 in neurons but that DHHC5 is the major endogenous
regulator of GRIP1 palmitoylation. Indeed, an antibody that
recognizes both DHHC5 and DHHC8 equally revealed that
DHHC5 is by far the major of these two PATs in our neuronal
cultures (Figure S2L). Thus, in subsequent experiments we
focused our attention on DHHC5.
Rapid GRIP1b Palmitate Turnover Suggests a Role
in Dynamic Trafficking
Although palmitoylation is reversible, rates of palmitate turnover
on neuronal proteins vary widely (Huang and El-Husseini, 2005;
Kang et al., 2008). Palmitate turnover rate can provide insight
into the possible function of palmitoylation; rapid turnover
suggests a role in dynamic events such as regulated protein
trafficking, while slow palmitate turnover suggests a role in
long-term static protein targeting. As a first step to address the
functional consequence of GRIP1b palmitoylation, we deter-
mined the palmitate turnover rate of GRIP1. Treating neurons
with the broad-spectrum palmitoylation inhibitor 2-Bromopalmi-
tate, which blocks palmitate addition (Webb et al., 2000; Resh,
2006), allows palmitate turnover rate to be measured by tracking
kinetics of palmitoylation ‘‘run down’’ in ABE samples. Strikingly,
almost all palmitate on GRIP1 was removed after only 1 hr of
2-Bromopalmitate treatment (Figure 3A). Indeed, GRIP1 palmi-
tate cycling was faster (half-time [T1/2] approximately 35 min,
Figure 3B) than any other protein that we examined, including
the well-known reversibly palmitoylated protein PSD-95 (El-Hus-
seini et al., 2002; Figures 3A and 3B) and approaches the fastest
turnover rates reported for any known palmitoyl-protein (Mageeability. HEK293T cells were transfected with GRIP1b plus either empty vector,
HHS5) or PDZ ligand mutant (HA-DHHC5DC). Lysates were subjected to ABE
ion (middle panel), and DHHC5 expression (lower panel).
r DHHC8wt, DHHS8 or DHHC8DC as indicated.
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Figure 2. DHHC5/8 Control GRIP1 Palmitoylation in Primary Neurons
(A) Top-row panels showprimary hippocampal neurons immunostained with antibodies against endogenous DHHC5 (first panel), DHHC8 (second panel), and the
synaptic marker Bassoon (third panel). A single highlighted dendrite (dashed rectangle in each upper-panel image) is shown at higher magnification in the
corresponding lower panel. Examples of colocalized DHHC8 and Bassoon puncta are indicated with arrows in the overlaid image.
(B) Immunostaining of primary hippocampal neurons cotransfected with myc-tagged DHHC5 and the soluble marker mCherry, and immunostained for the
synaptic marker PSD-95 plus myc and dsRed antibodies. A single highlighted dendrite (dashed rectangle in each upper-panel image) is shown at higher
magnification in the corresponding lower panel. An example of myc-DHHC5 colocalized with a PSD-95-positive dendritic spine is shown (arrow), but myc-
DHHC5 is more frequently found in dendritic shafts.
(C) Equal protein amounts of the indicated subcellular fractions were immunoblotted with DHHC5 or DHHC8 antibodies. Fidelity of the preparation was confirmed
by immunoblotting with PSD-95 antibody.
(D) Dendritic GRIP1 puncta frequently contain the GRIP1b isoform. Hippocampal neurons were immunostained with GRIP1 monoclonal and GRIP1b-specific
polyclonal antibodies as indicated. A single highlighted dendrite (dashed rectangle in each upper-panel image) is shown at higher magnification in the corre-
sponding lower panel. GRIP1 dendritic puncta that are GRIP1b-positive are indicated with arrows in the overlaid image.
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mitoylation most likely regulates dynamic events such as rapid
changes in protein trafficking.
Palmitoylation by DHHC5 Targets GRIP1b to Dendritic
Endosomes
Endogenous GRIP1b is highly palmitoylated (Figure 2E), but the
signal detected by GRIP1b immunostaining (Figure 2D) does not
discriminate between palmitoylated and nonpalmitoylated forms
of GRIP1b. We, therefore, sought to compare the neuronal distri-
bution of nonpalmitoylated and palmitoylated GRIP1b more
directly. Nonpalmitoylated GRIP1b was made by mutating the
single palmitoylated cysteine residue, Cys11, to a nonpalmitoy-
latable Serine (GRIP1b-C11S; Figure 3C). To mimic palmitoyla-
tion, we added a consensus sequence to the GRIP1b N terminus
that directs addition of myristate (C14, fully saturated), an almost
identical lipid to palmitate (C16, fully saturated), which is
attached at an almost identical position in the GRIP1b protein
(Figure 3C). Importantly, however, myristate modification is irre-
versible (Johnson et al., 1994), so myristoylated GRIP1b (Myr-
GRIP1b) mimics constitutively palmitoylated GRIP1b.
The distribution of GRIP1b-C11S and myr-GRIP1b differed
dramatically in hippocampal neurons. While GRIP1b-CS immu-
nofluorescence was restricted to the cell soma and proximal
dendrites, myr-GRIP1b immunofluorescence extended far into
distal dendrites (Figure 3D; quantified in Figure 3E). Even more
dramatically, while GRIP1b-CS immunofluorescence was
almost entirely diffuse, Myr-GRIP1b was strikingly punctate (Fig-
ure 3D; quantified in Figure 3F). Similar to endogenous GRIP1b,
Myr-GRIP1b puncta were present throughout dendritic shafts,
but only rarely present in dendritic spines (Figure S3A, quantified
in Figures S3B and S3C). Numerous Myr-GRIP1b puncta were
detected far (>60 mm) into distal dendrites, and their size and
distribution resembled previously described endogenous
GRIP1/GRIP1b puncta, which colocalize with markers for recy-
cling endosomes, but not with early endosome, synaptic, or
Golgi markers (Mao et al., 2010; Figures S2G and S2H). Indeed,
dendritic Myr-GRIP1b puncta colocalized extensively with Alexa
555 transferrin (Figure 3G), but only rarely with the early endoso-
mal marker EEA1 (Figure S3D), confirming their identity as
recycling endosomes. Moreover, live imaging of GFP-tagged
Myr-GRIP1b revealed that a subset of these recycling endo-
somes is highly motile (Movie S1). Together, these data suggest
that mimicking N-terminal palmitoylation targets GRIP1b to
motile dendritic trafficking endosomes.(E) High stoichiometry of GRIP1b palmitoylation in primary neurons and whole bra
lysed and immunoprecipitated with the indicated antibodies. [3H]signal (upper pa
cultured neurons subjected to ABE and immunoblotted with pan-GRIP1 (upper p
(F) Lysates from cortical neurons cultured for the indicated number of DIV were i
Lysates subjected to ABE were blotted to detect palmitoylated GRIP1b (bottom
(G) Cortical cultured neurons were infected with the indicated lentiviruses contain
PATs. A fraction of each lysate was immunoblotted to detect total levels of DHHC5
subjected to ABE to detect palmitoylated GRIP1 (second panel) and Fyn (fourth
(H) Quantitation of multiple experiments confirms that DHHC5 knockdown signifi
SEM], n = 8, p < 0.05 compared to control virus [FUGW] alone, t test), shRNA-resi
control virus, n = 8, not significant from FUGW alone), and GRIP1 palmitoylation
(6.9% ± 2.6% of control virus, n = 3. Asterisks indicate significant difference from
See also Figure S2.PDZ Ligand-Dependent Palmitoylation by DHHC5
Targets GRIP1b to Dendritic Vesicles
These findings suggested that wild-typeGRIP1bmight distribute
between the diffuse pattern of GRIP1b-C11S and the punctate
pattern of Myr-GRIP1b. However, dendritic puncta of trans-
fected GRIP1bwt were far less numerous than those seen with
Myr-GRIP1b (Figures 3D and 3F). We hypothesized that this
might be due to limiting endogenous DHHC5 PAT activity.
Consistent with this notion, transfection of wild-type DHHC5
transformed GRIP1bwt distribution in two ways. First, DHHC5wt
increased the level of GRIP1bwt detected in distal dendrites
(Figure 4A; quantitated in Figure 4B). Second, DHHC5wt
transformed GRIP1bwt staining from a largely diffuse pattern
to one that was strikingly punctate (Figure 4A; quantitated in Fig-
ure 4C). Indeed, the number of GRIP1bwt puncta in distal
dendrites of HA-DHHC5 expressing neurons approached that
seen with Myr-GRIP1b. Changes in GRIP1bwt distribution
were likely due to direct palmitoylation because HA-DHHC5wt
expression did not affect GRIP1b-C11S distribution. Strikingly,
neither DHHS5 nor DHHC5DC increased GRIP1b targeting to
dendrites (Figures 4A–4C), despite the normal dendritic targeting
of these mutants (Figure S4). Together, these results suggest
that palmitoylation by DHHC5 targets GRIP1b to recycling endo-
somes and that, as in heterologous cells (Figure 1G), this pheno-
typic effect requires both the PAT activity and PDZ binding ability
of DHHC5.
The rapid turnover of palmitate on GRIP1 suggested that
GRIP1 vesicular localizationmight be affected by acute inhibition
of palmitoylation. Indeed, acute treatment (90 min) with 2-Bro-
mopalmitate dramatically dispersed GRIP1 puncta in both
proximal and distal dendrites (Figure 5A). These findings are
consistent with palmitoylation reversibly targeting GRIP1b to
dendritic endosomes and suggested that palmitoylation might
modulate interactions with other GRIP1 partners that control
vesicle trafficking. One such trafficking protein is the dendritic ki-
nesinmotor protein KIF5, whose interaction with GRIP1 is critical
for GluA2 trafficking within dendrites (Setou et al., 2002). We,
therefore, addressed whether GRIP1 palmitoylation might
modulate GRIP1 interactions with KIF5, by coexpressing
KIF5C with wild-type, nonpalmitoylatable, or Myr-GRIP1b in
heterologous cells. Strikingly, myristoylated GRIP1 bound more
KIF5C than did wild-type GRIP1, while GRIP1b-C11S bound
KIF5C only minimally (Figure 5B). Moreover, in neurons a Myr-
GRIP1b mutant lacking the previously reported KIF5-binding
domain of GRIP1 (Setou et al., 2002; myr-GRIP1b-delKBD)in. Top panels show cultured neurons metabolically labeled with [3H]palmitate,
nel) and GRIP1 protein levels (lower panel) are shown. Bottom panels illustrate
anel) or GRIP1b-specific antibodies (lower panel).
mmunoblotted for expression of GRIP1b (top panel) or DHHC5 (middle panel).
panel).
ing shRNA sequences to knock down expression of DHHC5, DHHC8, or both
(top panel), GRIP1 (third panel), and Fyn (fifth panel). The remaining lysate was
panel).
cantly reduces GRIP1 palmitoylation (56.8% ± 7.2% of control virus [mean ±
stant DHHC5 (‘‘rescue’’) restores GRIP1 palmitoylation levels (95.5% ± 7.5% of
is almost completely eliminated by knockdown of both DHHC5 and DHHC8
control (FUGW)-infected neurons (p < 0.05, t test).
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Figure 3. Palmitoylation Targets GRIP1b to Specific Dendritic Endosomal Vesicles
(A) Primary neurons were treated with 100 mM 2-Bromopalmitate for the indicated times or with 0.1% (v/v) EtOH (solvent control). ABE reactions were performed
to detect palmitoylated and total levels of GRIP1 and PSD-95, as indicated.
(B) Quantitation of palmitate turnover from multiple experiments as in (A), plotted as mean ± SEM for four determinations per time point.
(C) Schematic of palmitoylated GRIP1b wild-type, compared to nonpalmitoylatable (GRIP1b-C11S) and constitutive palmitoylation-mimic (Myr-G1b). The
myristoylation consensus adds a similar lipid (C14, saturated) at amino acid 2 (Gly), following cleavage of the initiating methionine.
(D–F) Dendritic targeting of GRIP1b by lipid modification. (D) Representative images of primary hippocampal neurons transfected with GFP as a morphology
marker, plus either GRIP1bwt-myc (GRIP1wt, top row), GRIP1b-C11S-myc (GRIP1CS, middle row) or Myr-GRIP1b-myc (Myr-GRIP1, bottom row), following
fixation and staining with antibodies against GFP (first column) and myc (second column). The right column shows myc signals, thresholded at an identical value
for each transfected neuron. (E) Quantitation of average fluorescence (mean ± SEM) in cell soma and in dendritic segments at the indicated distances from the
soma, in neurons expressing GRIP1bwt-myc (n = 14), GRIP1b-C11S-myc (n = 16), or Myr-GRIP1b-myc (n = 15). Asterisks indicate significant difference (p < 0.05)
from GRIP1bwt. (F) Number of GRIP1b puncta per dendritic segment (mean ± SEM) for each neuron from (E) (plotted for three dendrites each from n = 14, n = 16
and n = 15 neurons) at the indicated distances from the cell soma.
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ures 5C and 5D). These findings suggest first that GRIP1b palmi-
toylation favors GRIP1b-KIF5 binding, that these interactions act
in concert to control GRIP1b dendritic targeting, and may
enhance the ability of GRIP1b to bridge vesicular cargoes,
particularly glutamate receptors, with dendritic motor proteins.
Membrane-Associated GRIP1b Accelerates AMPA
Receptor Recycling
GRIP1 regulates AMPA receptor targeting to dendrites and the
recycling of AMPA receptors to the plasma membrane following
NMDA receptor (NMDAR) activation (Setou et al., 2002; Mao
et al., 2010). We, therefore, hypothesized that GRIP1b palmitoy-
lation might in turn affect GRIP1b’s ability to regulate AMPA
receptor recycling. To address this possibility, we transfected
hippocampal neurons with wild-type, nonpalmitoylatable, or
constitutively membrane-targeted forms of GRIP1b, together
with a pHluorin-tagged GluA2 AMPA receptor, to which GRIP1
directly binds (Dong et al., 1997; Mao et al., 2010). The pHluorin
tag fluoresces brightly at neutral pH, as when the receptor is
present on the plasma membrane. Brief treatment with NMDA
drives internalization of pHGluA2 to recycling endosomes,
whose acidity (pH <6.6) dramatically quenches pHGluA2 fluores-
cence, while NMDA washout induces pHGluA2 recycling to the
plasma membrane and fluorescence recovery (Ashby et al.,
2004, Lin and Huganir, 2007; Thomas et al., 2008; Mao et al.,
2010; Figure 6A). Fluorescence of pHGluA2, therefore, acts as
a readout of receptor distribution and can be used to determine
rates and degrees of internalization and recycling. In particular
the T1/2 of fluorescence recovery time, derived from a single
exponential fit of the recycling phase, provides a quantitative
measure of recycling rate.
In neurons transfected with GRIP1bwt or GRIP1bC11S, rates
of pHGluA2 internalization and recycling were highly similar to
neurons transfected with vector alone (Figure 6B). However,
pHGluA2 recycling was markedly accelerated in neurons trans-
fected with Myr-GRIP1b (Figure 6C). This accelerated recycling
was also seen in neurons transfected with DHHC5, which is pre-
dicted to increase palmitoylation of endogenous GRIP1b
(Figures 6D and Figures S5A). Both Myr-GRIP1b and DHHC5
caused accelerated recycling of both somatic and dendritic
pHGluA2 (Figures 6 and Figures S5B–S5E). The effect of trans-
fected DHHC5 is likely due to direct palmitoylation of GRIP1b,
as although GluA2 is a known palmitoylated protein (Hayashi
et al., 2005), it is not detectably palmitoylated by DHHC5 (Fig-
ure S5B). AMPA receptor recycling is, therefore, significantly
accelerated under conditions where GRIP1b membrane attach-
ment is enhanced (Figures 6E and Figures S5E). Myr-GRIP1b,
which is targeted to trafficking vesicles, also colocalized exten-
sively with pH-GluA2 in dendritic puncta in fixed neurons (Fig-
ure S5C), suggesting that effects on trafficking were likely due
to a direct GRIP1b-pHGluA2 interaction.(G) Mimicking palmitoylation targets GRIP1b to recycling endosomes. Myr-GRIP
and stained with anti-myc antibodies. Lower panels show high-magnification im
indicated with white arrows in the overlaid image.
See also Figure S3.DISCUSSION
Here, we report that two PATs use a novel PDZ domain recogni-
tion mechanism to palmitoylate and control the distribution and
trafficking of GRIP1b. The role of GRIP1b palmitoylation is
distinct from that observed for many palmitoyl-proteins: palmi-
toylation targets GRIP1b tomotile trafficking vesicles in neuronal
dendrites, and drives accelerated recycling of AMPA-type gluta-
mate receptors. These findings are consistent with both the
dendritic localization of the major GRIP1 PAT, DHHC5, and the
known role of GRIP1 in the dendritic trafficking of its interacting
partners, most notably AMPA-type glutamate receptors (Setou
et al., 2002; Mao et al., 2010). Why, though, is palmitoylated
GRIP1b not detected at the plasma membrane, as observed
for several other palmitoylated proteins? A likely explanation is
that the GRIP1b N terminus lacks a second membrane-targeting
signal, such as an additional lipid modification site or a polybasic
sequence (Sigal et al., 1994; Dunphy and Linder, 1998; Resh,
2006). ‘‘Two signal’’ modification of this type is essential for
plasma membrane targeting of GFP, while GFP modified with
only a single lipid and lacking a polybasic sequence localizes
to intracellular vesicles that are most likely endosomes (McCabe
and Berthiaume, 2001). The ‘‘single signal’’ present in GRIP1b
would therefore be predicted to direct targeting to vesicles.
Querying databases for conserved N-terminal cysteines sur-
rounded by nonbasic residues may well reveal further proteins
that are targeted to vesicles by palmitoylation.
Several lines of evidence support the conclusion that palmi-
toylated GRIP1b is targeted to dendritic endosomes; endoge-
nous GRIP1b, which is highly palmitoylated, shows a dendritic
distribution very similar to the palmitoylation mimic Myr-GRIP1b.
Moreover, DHHC5 targets GRIP1bwt, but not the palmitoylation
mutant GRIP1b-C11S, to similar dendritic puncta. Notably,
though, the endosomal targeting of palmitoylated GRIP1b is
distinct from the synaptic targeting described for the closely
related palmitoylated GRIP2b (DeSouza et al., 2002; Misra
et al., 2010). Consistent with these reports, we also observed
prominent GRIP2b targeting to dendritic spines, which did not
require DHHC5 or DHHC8 coexpression (data not shown).
Although GRIP1 and GRIP2 can compensate for one another in
cerebellar Purkinje neurons (Takamiya et al., 2008), two related
issues likely underlie the distinct regulation of these two proteins
in forebrain. First, plasma membrane/synaptic targeting of
GRIP2b is consistent with the additional basic residues that
surround the palmitoylated cysteine at the GRIP2b N terminus,
compared to GRIP1b. Second, while the PDZ domains of
GRIP1 and GRIP2 are highly homologous, the KIF5-binding
region of GRIP1 (between PDZ6 and PDZ7; Setou et al., 2002)
is poorly conserved in GRIP2, suggesting that GRIP1 is unique
in its ability to interact with motor proteins that control vesicular
cargoes. In further support of their distinct regulation, we also
observed no increase in GRIP2b palmitoylation by either1b-myc transfected neurons were live labeled with Alexa 555 transferrin, fixed,
ages of an individual dendrite. Extensively colocalized dendritic puncta are
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Figure 4. Catalytic Activity and PDZDomain
Recognition by DHHC5 Target GRIP1bwt to
Dendritic Vesicles
(A) Representative images of primary hippo-
campal neurons transfected with GFP as
a morphology marker, GRIP1bwt-myc or GRIP1b-
C11S-myc and either empty vector, HA-
DHHC5wt, HA-DHHS5 or DHHC5DC, following
fixation and staining with antibodies against GFP
(first column), myc (second column), and HA tags
(fourth panels). The third column shows myc
signal, thresholded at an identical value for each
transfected neuron.
(B) Average fluorescence intensity of GRIP1b-myc
(mean ± SEM) was plotted as in Figure 3E for
GRIP1bwt-myc (n = 14), GRIP1bwt-myc plus HA-
DHHC5wt (n = 19), GRIP1bC11S plus HA-
DHHC5wt (n = 12), GRIP1bwt plus HA-DHHS5 (n =
15), and GRIP1bwt plus HA-DHHC5DC (n = 14).
(C) Dendritic puncta of GRIP1b-myc were counted
and plotted (mean ± SEM) as in Figure 3F. Data for
GRIP1bwt-myc from Figure 3 are replotted in (B)
and (C). Asterisks indicate significant difference
(p < 0.05, t test) fromGRIP1bwt alone. Quantitative
analysis of DHHC5 dendritic distribution
confirmed that DHHC5 mutants target equally
well, if not better, than DHHC5wt to distal
dendrites (see also Figure S4); thus, impaired tar-
geting does not account for their inability to
regulate GRIP1bwt distribution.
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shown), and a much slower GRIP2 palmitoylation turnover rate
in neurons, compared to GRIP1b (data not shown). Together,490 Neuron 73, 482–496, February 9, 2012 ª2012 Elsevier Inc.these findings suggest that palmitoylated
GRIP1b plays a unique role in endosomal
trafficking and coupling to kinesin motor
proteins.
Our finding that GRIP1b palmitoylation
specifically affects activity-dependent
AMPA-R recycling would appear to differ
from a recent report (Hanley and Henley,
2010), which implicates GRIP1b in
NMDA-induced AMPA-R internalization.
However, we suspect that experimental
differences likely underlie this discrep-
ancy and that our findings more accu-
rately reflect the physiological role of
GRIP1b. In particular, Hanley and Henley
used Sindbis virus infection to express
GRIP1b, a system that has two key issues
when used to study intracellular traf-
ficking. First, host cell protein synthesis
is shut down, complicating the analysis
of intracellular trafficking phenotypes.
Second, GRIP1b is overexpressed at
high levels, leading to intracellular aggre-
gation (visible in some images from this
report; Hanley and Henley, 2010). More-
over, the authors used a large, N-terminal(YFP) tag close to the site of GRIP1b palmitoylation, which may
well affect regulation of GRIP1b palmitoylation and/or functional
downstream effects that depend on this modification.
Figure 5. Rapid Turnover of Palmitate on GRIP1 Modulates Dendritic Targeting
(A) Acute treatment with 2-Bromopalmitate disperses dendritic GRIP1 puncta. Top panels show unprocessed images of GRIP1 immunostaining in GFP-
transfected hippocampal neurons. Middle panels illustrate GFP signal (morphology marker to outline individual dendrites). Lower panels indicate thresholded
puncta within the boundary of an individual GFP-transfected neuron following treatment with EtOH vehicle or 100 mM2-Bromopalmitate for 90min. Right panel is
a plot of the number of endogenous GRIP1 puncta (mean ± SEM) counted at indicated distances from the cell soma for three dendrites per cell from n = 19 cells
(control) and n = 21 cells (2-Br).
(B) Membrane-associated GRIP1b preferentially binds dendritic kinesin KIF5C in heterologous cells. HEK293 cells were transfected with HA-tagged KIF5C plus
the indicated myc-tagged GRIP1 constructs. Myc immunoprecipitates were immunoblotted for coimmunoprecipitated HA-KIF5C.
(C) Deletion of KBD impairs Myr-GRIP1b dendritic targeting. Top panels are representative images of primary hippocampal neurons transfected with GFP as
a morphology marker, plus either full-length Myr-GRIP1b-myc (Myr-GRIP1b) or Myr-GRIP1b lacking KBD (Myr-GRIP1b-delKBD), following fixation and staining
with antibodies against GFP (first row) and myc (second row). The bottom row shows myc signals, thresholded at an identical value for each transfected neuron.
(D) Average fluorescence intensity (mean ± SEM) of myc-tagged constructs in soma and dendrites, plotted as in Figure 3E for Myr-GRIP1b (n = 13) and Myr-
GRIP1b-delKBD (n = 12). Double asterisks indicate significant differences (p < 0.01, t test) between conditions at all distances from soma.
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lation approach (Mao et al., 2010) to circumvent many issues
associated with GRIP1 overexpression. This approach allowed
us to reveal a specific role for GRIP1 in activity-dependent recy-cling of both endogenous and exogenous (pHluorin-tagged)
AMPA-Rs. In contrast, we observed no role for GRIP1 on basal or
activity-induced AMPA-R internalization. The findings reported
here are highly consistent with the report by Mao et al. (2010)Neuron 73, 482–496, February 9, 2012 ª2012 Elsevier Inc. 491
Figure 6. Targeting GRIP1b to Membranes Increases Activity-Dependent GluA2 Recycling
(A) Representative images of fluorescence change of a hippocampal neuron expressing pH-GluA2, exposed at t = 10–20 mMNMDA for 5 min and then allowed to
recover following NMDA washout.
(B) Fluorescence change (mean ± SEM) during initial incubation, perfusion at t = 10 min with 20 mM NMDA for 5 min (blue bar) and washout, plotted for
hippocampal neurons transfected with pHluorin-taggedGluA2 (pH-GluA2) plus either empty vector (black circles, n = 11), myc-tagged GRIP1b wild-type (G1bwt,
red circles, n = 5) or GRIP1b-C11S (G1bCS, blue circles, n = 7).
(C) and (D) are the same as (B), but for neurons transfected with pH-GluA2 plus Myr-GRIP1b (Myr-G1b, orange circles, n = 6), or with HA-tagged DHHC5 (green
circles, n = 8), respectively. Recycling in DHHC5-transfected neurons is still accelerated when the fluorescence decrease is scaled to match vector controls
(Figure S5A).
(E) Time constants (T1/2) of fluorescence recovery, plotted as mean ± SEM for the curves in (B)–(D). Asterisks indicate significant difference from pHGluA2 alone
(p < 0.05, t test).
See also Figure S5.
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again observing a role for GRIP1 in activity-dependent AMPA-R
recycling. Moreover, in this study we also deliberately trans-
fected only small amounts of plasmid DNA, expressing GRIP1
from a weak promoter (see Experimental Procedures) to avoid
GRIP1b aggregation. Our GRIP1b constructs carried only a small
C-terminal myc tag far from the site of palmitoylation, which is
unlikely to interfere with GRIP1b function. Evidence frommultiple
readouts, using both endogenous and exogenous AMPA-Rs,
therefore, suggests that the predominant physiological role of492 Neuron 73, 482–496, February 9, 2012 ª2012 Elsevier Inc.GRIP1 is to control activity-dependent AMPA-R recycling, and
that palmitoylated GRIP1b enhances this process.
We note that, in addition to GRIP1b described here, their
prominent dendritic distribution suggests that DHHC5/8 are
well placed to palmitoylate other proteins at or near glutamater-
gic synapses. Although DHHC5 does not palmitoylate GluA2
(Figure S6B), its targets may include other AMPA-R subunits
(Hayashi et al., 2005), NMDARs (Hayashi et al., 2009), or other
PDZ domain adaptor proteins (Fukata and Fukata, 2010), all of
which are known to be palmitoylated. Indeed, other DHHC5
Neuron
GRIP1 Palmitoylation and Targeting by DHHC5/8substrates may underlie effects that cannot be fully attributed to
GRIP1b palmitoylation (e.g., the slightly reduced pHGluA2 fluo-
rescence decrease seen with DHHC5 transfection; Figure 6D).
In addition, the presence of transfected DHHC5 in long, aspiny
neurites that are likely axons, suggests that DHHC5 may palmi-
toylate additional axonal/presynaptic substrates in addition to its
dendritic regulation of GRIP1b described here.
The identification of additional DHHC5/8 substrates remains
an exciting area for future investigation. We note with interest
that other PATs cannot compensate for loss of DHHC5/8 to pal-
mitoylate GRIP1 in neurons, and in transfected cells even PATs
that display broad substrate specificity (DHHC3, DHHC7; Fukata
et al., 2004; Ferna´ndez-Hernando et al., 2006; Greaves et al.,
2008; Ponimaskin et al., 2008; Tsutsumi et al., 2009) or preferen-
tially palmitoylate cysteines located close to the N termini of their
substrates (DHHC20; Draper and Smith, 2010) do not palmitoy-
late GRIP1b (Figure S1). These findings suggest that GRIP1b
palmitoylation by DHHC5/8 has distinct requirements, namely
that the PDZ domain interaction unique to DHHC5 and DHHC8
is essential to render GRIP1b accessible as a substrate.
DHHC5, in particular, is a major GRIP1b PAT in neurons but
cannot palmitoylate several other palmitoyl-proteins (Fukata
et al., 2004; Ferna´ndez-Hernando et al., 2006; Greaves et al.,
2008; Tsutsumi et al., 2009), suggesting that PDZ domain-
dependent recognition is a key determinant of DHHC5 substrate
specificity.
Multiple studies link DHHC5 andDHHC8 to both normal higher
brain function and neuropsychiatric disease (Mukai et al., 2004,
2008; Li et al., 2010). However, to our knowledge, no neuronal
substrates have been identified for DHHC5, and although PSD-
95 palmitoylation is reduced in DHHC8 knockout mice (Mukai
et al., 2008), other PATs are also reported to directly palmitoylate
PSD-95 in neurons (Noritake et al., 2009), raising the possibility
that this may be an indirect effect. Thus, our identification of
GRIP1b as the first bona fide neuronal substrate for DHHC5/8
has broad implications, since GRIP1 is also genetically linked
to neuropsychiatric conditions and to autism (Grataco`s et al.,
2009; Mejias et al., 2011). This raises the possibility that
abnormal dendritic and/or synaptic palmitoylation of PDZ
domain proteins such as GRIP1 contributes to the pathogenesis
of these conditions. Indeed, another PDZ domain protein linked
to neuropsychiatric disease is also palmitoylated by DHHC5 and
DHHC8 in a PDZ ligand manner (G.M.T., T.H., and R.L.H.,
unpublished data). These findings raise the hope that therapeutic
targeting of specific PATs and/or their interactions with specific
substrates may provide a new approach to better therapeutic
treatments for these diseases.EXPERIMENTAL PROCEDURES
Antibodies
The following antibodies, from the indicated sources, were used in this study.
Monoclonal antibodies were GRIP1, Fyn, GM130 (BD Biosciences), PSD-95
(K28/43; Neuro mAb), GFP (3E6; Invitrogen), myc, HA11 (Covance), and HA
F-7 (Santa Cruz Biotechnology). Polyclonal antibodies were DHHC5 (Sigma-
Aldrich), ZDHHC8 (Everest Biotech), and rabbit anti-HA (QED Bioscience).
Antibody against the C terminus of GRIP1 has been previously described
(Dong et al., 1997). An antibody raised against the unique N terminus of
GRIP1b (amino acids 5–19; KKNIPICLQAEEEQER) was affinity purified usingthe antigenic peptide. Alexa dye-conjugated fluorescent secondary antibodies
and Alexa transferrin were from Invitrogen.
Molecular Biology and cDNA Clones
All mammalian DHHC5 and DHHC8 sequences reported share an identical
C-terminal 15 amino acids, terminating in a type II PDZ ligand. A C-terminal
109 amino acid ‘‘bait’’ from human DHHC8 (Ohno et al., 2006) was subcloned
into the pPC97 yeast expression vector and used to screen a rat hippocampal
cDNA library. Clones that grew on quadruple-deficient plates (Leu-, Trp-, His-,
Ade-) were selected, and their plasmids were isolated and sequenced. Posi-
tive clones were subcloned into myc-tagged pRK5 mammalian expression
vector, and C termini of both DHHC5 and DHHC8 were subcloned into
a mammalian GST fusion vector (Thomas et al., 2005) for binding experiments
in mammalian cells.
Full-length untagged rat GRIP1a and mouse GRIP1b cDNAs in pBK expres-
sion vector have been previously described (Dong et al., 1997; Yamazaki et al.,
2001). GRIP1b C11S was generated by QuikChange Site-Directed Mutagen-
esis Kit. A myristoylation consensus sequence (MGQSLTT; Wyszynski et al.,
2002) was added to the N terminus of GRIP1b-C11S by PCR to generate
Myr-GRIP1b. The myristoylation consensus contains no polybasic sequence
that might affect membrane targeting, and Myr-GRIP1b contained a mutated
Cys11- > Ser, so that only a single lipid modification occurs, as for GRIP1bwt.
For live imaging, full-length Myr-GRIP1b sequence was amplified by PCR and
subcloned into eGFP-N1 vector using NheI and NotI sites. HA-tagged mouse
DHHC5 and DHHC8 and mycHis-tagged human DHHC8 cDNA have been
previously described (Fukata et al., 2004; Ohno et al., 2006). Catalytically inac-
tive (DHHC - > DHHS) and deltaC (DC) mutants (lacking the last five amino
acids that constitute the PDZ ligand) of DHHC5 and DHHC8 were generated
by QuikChange. The previously reported kinesin-binding domain (KBD; Setou
et al., 2002) of GRIP1b was deleted by Splicing by Overlap Extension (SOE)-
based PCR using the Myr-GRIP1b-myc cDNA as template to generate Myr-
GRIP1b-myc-deltaKBD.
Lentiviral Infection and shRNA Knockdown
shRNAs (in vector pLKO; Mission shRNA library) targeting sequences identical
in both rat and mouse DHHC5 (50-CCTCAGATGATTCCAAGAGAT-30) or
DHHC8 (50-CTTCAGTATGGCTACCTTCAT-30) were tested for their ability to
reduce expression of HA-tagged DHHC5 and DHHC8 mouse cDNAs in co-
transfected HEK293T cells. After confirming that these sequences effectively
and specifically suppressed expression of DHHC5 and DHHC8, respectively,
each sequence was amplified by PCR, together with its neighboring H1
promoter. The resultant H1-shRNA cassettes were subcloned into the PacI
site of the lentiviral FUGW vector (Lois et al., 2002) and verified by sequencing.
ShRNA-resistant DHHC5 was generated by mutating five nucleotides within
the shRNA target sequence, without altering protein coding. This resultant
‘‘rescue’’ cDNA was amplified by PCR with SalI and NotI primers and inserted
into a modified FUGW vector by replacing the GFP cassette with myc-tagged
DHHC5.
VSV-G pseudotyped lentivirus was generated by standard methods. Briefly,
HEK293T cells were cotransfected with FUGW-shRNA vector and VSV-G and
Delta8.9 plasmid cDNAs using a Lipofectamine-based method. Supernatant
containing virus was harvested at 48 and 72 hr posttransfection, concentrated
by ultracentrifugation, resuspended in Neurobasal medium, and used to infect
dissociated neurons at 9 DIV. Neurons were lysed at 16 DIV.
Biochemistry
All biochemical experiments were performed at least three times, and in each
case a representative experiment is shown. Quantified analysis of certain
experiments is presented in Figure S1.
Radioactive and Nonradioactive Palmitoylation Assays
[3H]palmitate labeling of 293T cells and cultured neurons was performed as
described (Hayashi et al., 2005, 2009). ABE assaywas performed as described
(Hayashi et al., 2009), similar to published protocols (Drisdel et al., 2006; Wan
et al., 2007). For neuronal ABE experiments, neurons were lysed directly in
buffer containing 2% SDS and 20 mM methyl-methane thiosulfonate
(MMTS, to block free thiols). 2-Bromopalmitate was prepared as a 100 mMNeuron 73, 482–496, February 9, 2012 ª2012 Elsevier Inc. 493
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Sister cultures were treated with solvent control (0.1% [v/v] ethanol).
For ABE analysis of forebrain, one mouse (P21) forebrain was homogenized
in ice-cold buffer containing 10 mM HEPES (pH 7.4), 0.32 M sucrose, 20 mM
MMTS, and protease inhibitors. Unhomogenized tissuewas pelleted by centri-
fugation at 2,100 3 g, and the supernatant was rapidly warmed to room
temperature, adjusted to 1% (w/v; final concentration) SDS, centrifuged at
27,000 3 g to remove insoluble material, and used for ABE as above.
Transfection
HEK293T cells were transfected using a calcium phosphate-based method as
previously described (Thomas et al., 2005). Neurons were transfected using
a Lipofectamine-basedmethod and used for live imaging or fixed with parafor-
maldehyde (see below) either 10–16 hr later (for GRIP1 transfections) or 72 hr
later (for pHluorin-GluA2 transfections).
Coprecipitation in HEK293T Cells
HEK293T cells were transfected with pCIS vector constructs to express GST
alone, GST fusions of DHHC5 andDHHC8wild-type orDCC termini, plusmyc-
tagged GRIP456. Cells were lysed in immunopreciptation buffer (IPB; Thomas
et al., 2005) containing protease and phosphatase inhibitors. Insoluble mate-
rial was pelleted by centrifugation, and the supernatants (termed lysates)
were incubated with Glutathione Sepharose (GE Healthcare). Beads were
washed extensively with IPB, denatured in SDS sample buffer, and samples
were subjected to SDS-PAGE. Gels were transferred to PVDF membranes
and immunoblotted with anti-myc or anti-GST antibodies. For GRIP1-KIF5
binding, each GRIP1 construct, containing a C-terminal myc tag, was cotrans-
fected with HA-tagged KIF5C. Cells were lysed 16 hr after transfection and
lysates processed as above.
Cultured Primary Neurons
E18 embryos from timed-pregnant female rats were used to prepare cultured
neurons. All animals were treated in accordance with the Johns Hopkins
University Animal Care and Use Committee guidelines. Cortical neurons
were prepared as described (Thomas et al., 2008) and used at 16–20 DIV.
Hippocampal neurons on coverslips were prepared by the method of Goslin
and Banker (1998) for fixed immunostaining of endogenous proteins; or as
previously described (Lin and Huganir, 2007) for transfection experiments.
Transfection was performed at 15–17 DIV. All neuronal experiments were per-
formed from the indicated numbers of individual neurons, using at least two
different sets of cultures. Pooled data from each condition are plotted as
mean ± SEM, and statistical significance was determined by t test or ANOVA.
Immunostaining
Neurons on coverslips were fixed in PBS containing 4% (w/v) sucrose and 4%
(w/v) paraformaldehyde. Coverslips were washed with PBS and cells permea-
bilized with PBS containing 0.25% (w/v) Triton X-100. Following brief washing
with PBS, coverslips were blocked overnight at 4C in 10% normal goat serum
(NGS) diluted in PBS. Coverslips were then incubated with primary antibodies
(diluted in 10%NGS) for 3 hr at room temperature, washedwith PBS, and incu-
bated with fluorescent-conjugated goat-anti-rabbit or goat anti-mouse
secondary antibodies. In some experiments, isotype-specific (Alexa-conju-
gated goat anti-mouse IgG1 or goat anti-mouse IgG2a) secondary antibodies
were used.
For live-cell labeling with Alexa 555 transferrin, hippocampal neurons trans-
fected with Myr-GRIP1b-myc as above were incubated for 1 hr at 37C in
recording buffer (Lin and Huganir, 2007), then for 20 min at 37C in recording
buffer containing 25 mg/ml Alexa 555 transferrin. Unbound Alexa 555 trans-
ferrin was removed by three quick washes in recording buffer, prior to fixation,
permeabilization, and incubation with anti-myc antibody.
Microscopy and Image Analysis
The majority of neuronal images were acquired using a laser-scanning
confocal microscope (LSM 510; Zeiss) with a 633 oil immersion Neofluor
objective (N.A.1.3; Zeiss). Some images were acquired using a comparable
system (Nikon C2 confocal) with a 603 objective (N.A. 1.4; Nikon). For fixed-
cell imaging, multiple individual sections (1.0 Airy Units, approximately494 Neuron 73, 482–496, February 9, 2012 ª2012 Elsevier Inc.0.4 mm slices) of a neuron of interest were acquired to capture the entire
dendritic tree. A single maximum intensity projection was then generated
from these confocal z stacks.
Analysis of Dendritic Puncta and Neuronal Morphology
Offline image analysis was performed with NIH ImageJ software. To analyze
the dendritic distribution of transfected GRIP1, a single maximum-intensity
projection image was generated. The average somatic fluorescence intensity
in the cell body was calculated bymanually tracing the soma, using signal from
cotransfected GFP to determine morphology. The GFP fill was then used to
trace 20 mm segments along the three most prominent dendrites emanating
from the cell body. Each dendritic segment was then outlined in the GRIP1-
myc channel and the average fluorescence intensity logged to a spreadsheet.
The analysis was repeated at 20 mmsteps for each image. Similar analysis was
performed to determine the dendritic distribution of transfected DHHC5 (wild-
type and mutants) and DHHC3.
To quantitate dendritic puncta of transfected GRIP1, each dendritic
segment (outlined in the GRIP1-myc channel as above) was thresholded by
gray value at a level close to 50% of the dynamic range. This threshold value
was kept constant for all images in each condition, and background noise from
these images was negligible. The same dendritic regions were outlined as
above, the software was used to count puncta of 2–20 pixel units within
each segment, and the results were logged to a spreadsheet. The analysis
was repeated at 20 mm steps for each image.
To analyze the effect of 2-Bromopalmitate on endogenous GRIP1 puncta,
images were initially thresholded as above. A new image was generated of
those puncta that overlapped a GFP-transfected neuron within the same field.
This allowed GRIP1 signals to be assigned to dendrites emanating from
a specific neuron with a defined center. The soma was traced and masked
manually, and the GFP signal was used to trace 20 mm dendritic segments
as above. Puncta in each dendritic segment were counted as above and
logged to a spreadsheet.
Live Imaging of pHluorin-Tagged GluA2
Live imaging was performed essentially as described (Lin and Huganir, 2007;
Thomas et al., 2008). Briefly, neurons on coverslips were transfected with pH-
GluA2 plus vector, GRIP1b wild-type or mutants, or HA-DHHC5. Seventy-two
hours after transfection, coverslips were assembled in a chamber perfused
with imaging buffer (Lin and Huganir, 2007; Thomas et al., 2008). A single
neuron was selected based on pHluorin signal, and baseline fluorescence
was monitored for 10 min prior to perfusion for 5 min with 20 mM NMDA in
low-magnesium imaging buffer (Lin and Huganir, 2007; Thomas et al., 2008)
and subsequent recovery in standard imaging buffer. Using ImageJ, the
change of pHGluA2 fluorescence in both the cell soma and in a single primary
dendrite was monitored and logged to a spreadsheet.
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